<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30081782</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>22</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1875-5305</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>25</Volume>                    <Issue>8</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Protein and peptide letters</Title>                <ISOAbbreviation>Protein Pept. Lett.</ISOAbbreviation>            </Journal>            <ArticleTitle>Sensitive and Selective Immunofluorescence Assay for CA15-3 Detection Using Fluorescein Derivative A10254.</ArticleTitle>            <Pagination>                <MedlinePgn>776-782</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2174/0929866525666180806113236</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Carbohydrate antigen 15-3 (CA15-3), a specific breast cancer-related biomarker in serum, can provide direct information to monitor a patient's postoperative status and can predict recurrence and metastasis of breast cancer. The conventional Enzyme-Linked Immunosorbent Assay (ELISA) is an effective approach for CA15-3 detection, but there is a high limit of detection which is more than 1 U mL-1. Therefore, a convenient, highly sensitive and specific CA15-3 detection method is needed for earlier prognoses of breast cancer.</AbstractText>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In this work, we aim to develop a novel sensitive and selective immunofluorescence assay for the highly effective detection of CA15-3.</AbstractText>                <AbstractText Label="METHOD" NlmCategory="METHODS">We pre-coat the antibody I onto the solid phase to capture antigen CA15-3. The A10254- labeled antibody II identified by electrophoresis and fluorescence spectra recognized the antigen CA15-3 and formed the sandwich format. The fluorescence signal of A10254 directly relating to the amount of antigen could be detected and quantified by the microplate reader excited at 440nm.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The obtained method for CA15-3 detection showed lower limits of detection (0.11 and 0.18 U mL-1) in a linear range of 0.25-14 U mL-1 in the buffer and 2% serum, respectively. This assay exhibited a good specificity and reproducibility in 2% serum with lower relative standard deviations in different tested concentrations.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The developed immunofluorescence assay enhanced the performance of the conventional CA15-3 ELISA kit. Moreover, the acceptable accuracy and good reproducibility in diluted serum indicated the assay has great potential for the diagnosis of breast cancer in clinical practice.</AbstractText>                <CopyrightInformation>CopyrightÂ© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Huang</LastName>                    <ForeName>Xiaoting</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry, Tsinghua University, Beijing, 100084, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Haiyang</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry, Tsinghua University, Beijing, 100084, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fang</LastName>                    <ForeName>Wei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry, Tsinghua University, Beijing, 100084, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Yan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tan</LastName>                    <ForeName>Ying</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry, Tsinghua University, Beijing, 100084, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, The Graduate School at Shenzhen, Tsinghua University, Shenzhen, Guangdong 518055, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Protein Pept Lett</MedlineTA>            <NlmUniqueID>9441434</NlmUniqueID>            <ISSNLinking>0929-8665</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">CA15-3 detection</Keyword>            <Keyword MajorTopicYN="N">Immunofluorescence assay</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">sandwich format</Keyword>            <Keyword MajorTopicYN="N">sensitivity</Keyword>            <Keyword MajorTopicYN="N">specificity.</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30081782</ArticleId>            <ArticleId IdType="pii">PPL-EPUB-92185</ArticleId>            <ArticleId IdType="doi">10.2174/0929866525666180806113236</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>